SUSMEDInc Past Earnings Performance
Past criteria checks 0/6
SUSMEDInc's earnings have been declining at an average annual rate of -4.7%, while the Healthcare Services industry saw earnings growing at 17.3% annually. Revenues have been growing at an average rate of 31.3% per year.
Key information
-4.7%
Earnings growth rate
4.6%
EPS growth rate
Healthcare Services Industry Growth | 19.2% |
Revenue growth rate | 31.3% |
Return on equity | -7.8% |
Net Margin | -104.4% |
Next Earnings Update | 08 Nov 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How SUSMEDInc makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 342 | -357 | 452 | 243 |
31 Mar 24 | 340 | -357 | 452 | 240 |
31 Dec 23 | 732 | 49 | 446 | 233 |
30 Sep 23 | 531 | -104 | 420 | 209 |
30 Jun 23 | 530 | -50 | 394 | 176 |
31 Mar 23 | 525 | 2 | 370 | 145 |
31 Dec 22 | 128 | -335 | 349 | 144 |
30 Sep 22 | 317 | -196 | 337 | 164 |
30 Jun 22 | 316 | -233 | 309 | 226 |
30 Jun 21 | 115 | -277 | 190 | 249 |
30 Jun 20 | 34 | -96 | 107 | 86 |
Quality Earnings: 4263 is currently unprofitable.
Growing Profit Margin: 4263 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4263 is unprofitable, and losses have increased over the past 5 years at a rate of 4.7% per year.
Accelerating Growth: Unable to compare 4263's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4263 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (11.9%).
Return on Equity
High ROE: 4263 has a negative Return on Equity (-7.75%), as it is currently unprofitable.